Matica Biolabs to manufacture TiCARos' new cancer therapy drugs for clinical trials

CHA Biotech subsidiary Matica Biolabs signed a contract to manufacture medical developer TiCARos' new CAR-T cancer therapy drugs for clinical trials, the companies said Wednesday.